Sukoff et al. demonstrated that continuously increased levels of IL-6 in the central nervous system (CNS) can lead to depression-like phenotype in rodents, while sgp130 FC can significantly reduce IL-6 levels and improve depression-like behavior, suggesting the anti-inflammatory and antidepressant effects of sgp130 [38]. Here, IL6 is linked to depressive disorder.